Bio - Elizabeth Thompson | Friends of Cancer Research

You are here

Bio - Elizabeth Thompson

Elizabeth Thompson

Chief Executive Officer

National Osteoporosis Foundation

 

Liz Thompson serves as the chief executive officer of the National Osteoporosis Foundation, the nation’s only organization dedicated to preventing osteoporosis and broken bones, promoting strong bones for life and reducing human suffering through awareness programs for the public and clinicians, education, advocacy and research. Osteoporosis is a major public health threat for an estimated 54 million Americans. One in two women and up to one in four men over age 50 will break a bone due to osteoporosis in their lifetime and approximately 75,000 Americans will die every year due to fractures.

 

Liz is widely regarded for her 30 years of national and global leadership experience spanning for-profit and for-purpose organizations. She has a track record of engaging diverse stakeholders to set a common agenda for impact, raising money for research, and advocating for evidence-based high quality and high value care. Some career highlights:

  • In her first year at NOF, Liz recognized that major initiatives in quality were needed in order to advance bone health and formed the National Bone Health Policy Institute standing it up with a seed investment of $1.2M. It will officially launch in January 2019 with an economic report at the National Press Club.
  • Prior to joining the National Osteoporosis Foundation, Liz served as the President and CEO of C-Change and played a lead role in setting the national conversation around value-based cancer care. In that role, she worked passionately and tirelessly, dedicated to building a strong membership organization that harnessed the power of a movement to create research agendas, drive public policy, open access to life saving medicines, and empower people to live healthier, stronger lives.
  • As president of Susan G. Komen for the Cure, Liz transformed the culture of philanthropy on the base of the $2.9B portfolio resulting in strategic grant making in science and research, expanded community health grant making in at-risk US communities and 50 countries around the world. A world brand leader committed to world-wide impact, she engaged with more than 200 corporate and strategic alliances to jump start Pink Ribbon/Red Ribbon, an effort focused on providing diagnostic and treatment services for women who were living beyond HIV/AIDS and succumbing to cervical and breast cancer.
  • In her early career, she worked in medical and consumer healthcare publishing and through that work and her advocacy work, has had the privilege to learn from dedicated physician scientists and their patients who are making advances and innovation possible.